Investing
Also, Lunit has completed its acquisition of breast screening AI company Volpara.
The company offers adults and children virtual care sessions with therapists, homework and educational content.
The Delaware-based company provides self-insured employers with data and strategies to reduce costs associated with prescription medications.
The company's stock price dropped after it released its first-quarter earnings and lowered its full-year guidance despite an increase in revenue.
Payments and revenue cycle-management company Sift Healthcare, nursing-scheduling and management platform In-House Health, and analytics and risk-stratification company OptMyCare also secured funding.
The company, which tailors cybersecurity offerings to health systems and providers, also appointed its first chief executive officer, Geyer Jones.
The company will use the funds to accelerate its AI capabilities and for strategic and commercial growth.
GenAI company for health plans Alaffia Health and oncology-focused clinical-trial platform Klineo also secured funding.
It is envisioned to cover greater distances, serving Australia's rural and remote communities, while being sustainable.
The startup plans to use the funds to build out its technology platform.